Inventor · disambiguated record
Lynne Canne Bannen
Also filed as: BANNEN LYNNE · BANNEN LYNNE CANNE
23 granted patents·19 pending applications·484 citations·filing 2003–2023
96Inventor score
Files withEXELIXIS INC23BANNEN LYNNE CANNE9ASSEMBLY BIOSCIENCES INC4SYMPHONY EVOLUTION INC3ANAND NEEL K1
Top patents by PatentIndex Score
42 records- 0198US7579473B2c-Met modulators and methods of useEXELIXIS INC·Filed 2009·Granted Aug 25, 2009·95 cites·7 claims
- 0297US8497284B2C-met modulators and method of useBANNEN LYNNE CANNE·Filed 2011·Granted Jul 30, 2013·60 cites·23 claims
- 0397US8067436B2c-Met modulators and methods of useBANNEN LYNNE CANNE·Filed 2007·Granted Nov 29, 2011·59 cites·4 claims
- 0496US9174947B2c-Met modulators and methods of useBANNEN LYNNE CANNE·Filed 2006·Granted Nov 3, 2015·45 cites·6 claims
- 0596US8476298B2c-Met modulators and method of useBANNEN LYNNE CANNE·Filed 2007·Granted Jul 2, 2013·39 cites·11 claims
- 0696US8178532B2c-Met modulators and method of useBANNEN LYNNE CANNE·Filed 2007·Granted May 15, 2012·46 cites·3 claims
- 0796US7989622B2Phosphatidylinositol 3-kinase inhibitors and methods of their useEXELIXIS INC·Filed 2006·Granted Aug 2, 2011·64 cites·7 claims
- 0895US11124482B2C-met modulators and methods of useEXELIXIS INC·Filed 2017·Granted Sep 21, 2021·6 cites·11 claims
- 0995US7977345B2c-MET modulators and method of useEXELIXIS INC·Filed 2005·Granted Jul 12, 2011·48 cites·3 claims
- 1084US11542259B2Compounds for the treatment of kinase-dependent disordersEXELIXIS INC·Filed 2019·Granted Jan 3, 2023·3 cites·2 claims
- 1183US11708367B2Compounds for the treatment of kinase-dependent disordersEXELIXIS INC·Filed 2019·Granted Jul 25, 2023·2 cites·20 claims
- 1278US11560370B15-membered heteroaryl carboxamide compounds for treatment of HBVASSEMBLY BIOSCIENCES INC·Filed 2019·Granted Jan 24, 2023·1 cites·30 claims
- 1378US8076338B2Kinase modulators and methods of useANAND NEEL K·Filed 2005·Granted Dec 13, 2011·7 cites·53 claims
- 1475US12195475B2Compounds for the treatment of kinase-dependent disordersEXELIXIS INC·Filed 2023·Granted Jan 14, 2025·0 cites·12 claims
- 1575US10035790B2RORγ modulatorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Jul 31, 2018·3 cites·13 claims
- 1675US2020331860A1C-Met Modulators and Methods of UseEXELIXIS INC·Filed 2020·Application pending·0 cites
- 1774US7989661B2Human ADAM-10 inhibitorsSYMPHONY EVOLUTION INC·Filed 2009·Granted Aug 2, 2011·1 cites·10 claims
- 1872US12030869B25-membered heteroaryl carboxamide compounds for treatment of HBVASSEMBLY BIOSCIENCES INC·Filed 2022·Granted Jul 9, 2024·0 cites·5 claims
- 1972US8889664B2Phosphatidylinositol 3-kinase inhibitors and methods of their useBAJJALIEH WILLIAM·Filed 2011·Granted Nov 18, 2014·3 cites·10 claims
- 2072US2024150371A1Compounds for the Treatment of Kinase-Dependent DisordersEXELIXIS INC·Filed 2023·Application pending·0 cites
- 2170US2024043414A1Compounds for the Treatment of Kinase-Dependent DisordersEXELIXIS INC·Filed 2022·Application pending·0 cites
- 2266US7629341B2Human ADAM-10 inhibitorsSYMPHONY EVOLUTION INC·Filed 2003·Granted Dec 8, 2009·2 cites·34 claims
- 2366US2014155396A1C-Met Modulators and Method of UseEXELIXIS INC·Filed 2013·Application pending·0 cites
- 2466US2014155378A9c-Met Modulators and Method of UseEXELIXIS INC·Filed 2013·Application pending·0 cites
- 2564US2016185725A1c-Met Modulators and Method of UseEXELIXIS INC·Filed 2016·Application pending·0 cites
- 2663US2012184523A1C-Met Modulators and Method of UseBANNEN LYNNE CANNE·Filed 2012·Application pending·0 cites
- 2762US11673897B2Compounds for the treatment of kinase-dependent disordersEXELIXIS INC·Filed 2019·Granted Jun 13, 2023·0 cites·14 claims
- 2862US2022023311A1Hepatitis b core protein modulatorsASSEMBLY BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 2962US2015376133A1C-Met Modulators and Methods of UseEXELIXIS INC·Filed 2015·Application pending·0 cites
- 3061US2014206865A1Human Adam-10 InhibitorsSYMPHONY EVOLUTION INC·Filed 2014·Application pending·0 cites
- 3160US2011077233A1C-Met Modulators and Method of UseEXELIXIS INC·Filed 2010·Application pending·0 cites
- 3258US2013144056A1Human Adam-10 InhibitorsBANNEN LYNNE CANNE·Filed 2012·Application pending·0 cites
- 3356US10987360B2Hepatitis B core protein modulatorsASSEMBLY BIOSCIENCES INC·Filed 2017·Granted Apr 27, 2021·0 cites·16 claims
- 3455US2012071653A1Human Adam-10 InhibitorsBANNEN LYNNE CANNE·Filed 2011·Application pending·0 cites
- 3553US12503438B2Compounds for the treatment of kinase-dependent disordersEXELIXIS INC·Filed 2020·Granted Dec 23, 2025·0 cites·10 claims
- 3653US2024158393A1Pyridone compounds and methods of useEXELIXIS INC·Filed 2022·Application pending·0 cites
- 3750US2022089541A1Compounds for the Treatment of Kinase-Dependent DisordersEXELIXIS INC·Filed 2020·Application pending·0 cites
- 3850US2015202196A1Methods of Using C-Met ModulatorsEXELIXIS INC·Filed 2014·Application pending·0 cites
- 3949US2023151003A1Compounds and methods of useEXELIXIS INC·Filed 2021·Application pending·0 cites
- 4047US12371428B2Pyridone compounds and methods of useEXELIXIS INC·Filed 2020·Granted Jul 29, 2025·0 cites·27 claims
- 4144US2012070368A1Methods of Using C-Met ModulatorsBANNEN LYNNE CANNE·Filed 2011·Application pending·0 cites
- 4233US2010249071A1Modulators of S1P and Methods of Making And UsingEXELIXIS INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lynne Canne Bannen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →